• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Jerry Younger, MD

Publications

  • Michaelson JS, Chen LL, Bush D, Fong A, Smith B, Younger J.Improved web-based calculators for predicting breast carcinoma outcomes.Breast Cancer Res Treat. 2011 Feb 15.
    21327471
  • Bush D, Smith B, Younger J, Michaelson JS.The non-breast-cancer death rate among breast cancer patients.Breast Cancer Res Treat. 2010 Oct 7.
    20927583
  • Michaelson JS, Chen LL, Silverstein MJ, Cheongsiatmoy JA, Mihm MC, Sober AJ, Tanabe KK, Smith BL, Younger J.Why cancer at the primary site and in the lymph nodes contributes to the risk of cancer death.Cancer. 2009 Nov 1;115(21):5084-94.
    19670457
  • Chen LL, Nolan ME, Silverstein MJ, Mihm MC, Sober AJ, Tanabe KK, Smith BL, Younger J, Michaelson JS.The impact of primary tumor size, lymph node status, and other prognostic factors on the risk of cancer death.Cancer. 2009 Nov 1;115(21):5071-83.
    19658184
  • Michaelson JS, Chen LL, Silverstein MJ, Mihm MC, Sober AJ, Tanabe KK, Smith BL, Younger J.How cancer at the primary site and in the lymph nodes contributes to the risk of cancer death.Cancer. 2009 Nov 1;115(21):5095-107.
    19670458
  • Hesketh PJ,Younger J,Sanz-Altamira P,Hayden M,Bushey J,Trainor B,Krentzin M,Nowd P,Arnaoutakis K,Hesketh AM.Aprepitant as salvage antiemetic therapy in breast cancer patients receiving doxorubicin and cyclophosphamide.Support Care Cancer. 2008 Dec 6.
    19066985
  • Burstein HJ,Chen YH,Parker LM,Savoie J,Younger J,Kuter I,Ryan PD,Garber JE,Chen H,Campos SM,Shulman LN,Harris LN,Gelman R,Winer EP.VEGF as a marker for outcome among advanced breast cancer patients receiving anti-VEGF therapy with bevacizumab and vinorelb
    19047116
  • Eichler AF, Kuter I, Ryan P, Schapira L, Younger J, Henson JW.Survival in patients with brain metastases from breast cancer: the importance of HER-2 status.Cancer. 2008 Jun;112(11):2359-67.
    18361426
  • Lin NU, Carey LA, Liu MC, Younger J, Come SE, Ewend M, Harris GJ, Bullitt E, Van den Abbeele AD, Henson JW, Li X, Gelman R, Burstein HJ, Kasparian E, Kirsch DG, Crawford A, Hochberg F, Winer EP.Phase II trial of lapatinib for brain metastases in patients
    18421051
  • Liu MC, Demetri GD, Berry DA, Norton L, Broadwater G, Robert NJ, Duggan D, Hayes DF, Henderson IC, Lyss A, Hopkins J, Kaufman PA, Marcom PK, Younger J, Lin N, Tkaczuk K, Winer EP, Hudis CA.Dose-escalation of filgrastim does not improve efficacy: Clinical
    18234424
  • Younger JF, Plein S, Barth J, Ridgway JP, Ball SG, Greenwood JP.Troponin-I concentration 72 h after myocardial infarction correlates with infarct size and presence of microvascular obstruction.Heart. 2007 Dec;93(12):1547-51.
    17540686
  • Kornblith AB, Powell M, Regan MM, Bennett S, Krasner C, Moy B, Younger J, Goodman A, Berkowitz R, Winer E.Long-term psychosocial adjustment of older vs younger survivors of breast and endometrial cancer.Psychooncology. 2007 Oct;16(10):895-903.
    17245695
  • Burstein HJ, Overmoyer B, Gelman R, Silverman P, Savoie J, Clarke K, Dumadag L, Younger J, Ivy P, Winer EP.Rebeccamycin analog for refractory breast cancer: a randomized phase II trial of dosing schedules.Invest New Drugs. 2007 Apr;25(2):161-4.
    16969707
  • Burstein HJ, Parker LM, Keshaviah A, Doherty J, Partridge AH, Schapira L, Ryan PD, Younger J, Harris LN, Moy B, Come SE, Schumer ST, Bunnell CA, Haldoupis M, Gelman R, Winer EP.Efficacy of pegfilgrastim and darbepoetin alfa as hematopoietic support for do
    16293865
  • Ma XJ, Wang Z, Ryan PD, Isakoff SJ, Barmettler A, Fuller A, Muir B, Mohapatra G, Salunga R, Tuggle JT, Tran Y, Tran D, Tassin A, Amon P, Wang W, Wang W, Enright E, Stecker K, Estepa-Sabal E, Smith B, Younger J, Balis U, Michaelson J, Bhan A, Habin K, Baer
    15193263
  • Bendell JC, Domchek SM, Burstein HJ, Harris L, Younger J, Kuter I, Bunnell C, Rue M, Gelman R, Winer E.Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma.Cancer. 2003 Jun 15;97(12):2972-7.
    12784331
  • Burstein HJ, Harris LN, Gelman R, Lester SC, Nunes RA, Kaelin CM, Parker LM, Ellisen LW, Kuter I, Gadd MA, Christian RL, Kennedy PR, Borges VF, Bunnell CA, Younger J, Smith BL, Winer EP.Preoperative therapy with trastuzumab and paclitaxel followed by sequ
    12506169
  • Taghian AG, Assaad SI, Niemierko A, Kuter I, Younger J, Schoenthaler R, Roche M, Powell SN.Risk of pneumonitis in breast cancer patients treated with radiation therapy and combination chemotherapy with paclitaxel.J Natl Cancer Inst. 2001 Dec 5;93(23):1806
    11734597
  • Burstein HJ, Kuter I, Campos SM, Gelman RS, Tribou L, Parker LM, Manola J, Younger J, Matulonis U, Bunnell CA, Partridge AH, Richardson PG, Clarke K, Shulman LN, Winer EP.Clinical activity of trastuzumab and vinorelbine in women with HER2-overexpressing m
    11352965
  • Duffy LS, Greenberg DB, Younger J, Ferraro MG.Iatrogenic acute estrogen deficiency and psychiatric syndromes in breast cancer patients.Psychosomatics. 1999 Jul-Aug;40(4):304-8.
    10402875
  • FitzGerald MG, MacDonald DJ, Krainer M, Hoover I, O'Neil E, Unsal H, Silva-Arrieto S, Finkelstein DM, Beer-Romero P, Englert C, Sgroi DC, Smith BL, Younger JW, Garber JE, Duda RB, Mayzel KA, Isselbacher KJ, Friend SH, Haber DA.Germ-line BRCA1 mutatio
    8531968
  • Wood WC, Budman DR, Korzun AH, Cooper MR, Younger J, Hart RD, Moore A, Ellerton JA, Norton L, Ferree CR.Dose and dose intensity of adjuvant chemotherapy for stage II, node-positive breast carcinoma.N Engl J Med. 1994 May 5;330(18):1253-9.
    8080512